FDA: Data suggests Abbott’s rapid coronavirus diagnostic test is delivering inaccurate results

- Advertisement -
KEY POINTS
  • The U.S. Food and Drug Administration issued an alert on Thursday saying there is early data that suggests  Abbott Labs’ rapid coronavirus diagnostic test for Covid-19 may be delivering inaccurate results.
  • Specifically, the Abbott ID NOW test may return false negative results, the FDA said.
- Advertisement -
- Advertisement -
- Advertisement -
A box containing a 5-minute test for COVID-19 from Abbott Laboratories is pictured during the daily briefing on the novel coronavirus, COVID-19, in the Rose Garden of the White House in Washington, DC, on March 30, 2020.
A box containing a 5-minute test for COVID-19 from Abbott Laboratories is pictured during the daily briefing on the novel coronavirus, COVID-19, in the Rose Garden of the White House in Washington, DC, on March 30, 2020.
Mandel Ngan | AFP | Getty Images

The U.S. Food and Drug Administration issued an alert on Thursday saying there is early data that suggests  Abbott Labs’ rapid Covid-19 diagnostic test for may be delivering inaccurate results.

Specifically, the Abbott ID NOW test may return false negative results, the FDA said.

“We are still evaluating the information about inaccurate results and are in direct communications with Abbott about this important issue,” said Tim Stenzel, director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, in a statement. “We will continue to study the data available and are working with the company to create additional mechanisms for studying the test.”

Despite these concerns, ID NOW may continue to be used to correctly identify positive cases, but negative results may need confirmation from a high-sensitivity authorized molecular test Stenzel said.

Abbott’s share price dropped following the FDA alert, and it is down more than 3% in after-hours trading.

The FDA alert comes a day after researchers at New York University published a study claiming the ID NOW test missed a third of samples collected with nasopharyngeal swabs that tested positive with a test from rival Cepheid.

Abbott Labs refuted the NYU study’s claims that its rapid coronavirus diagnostic test could be missing nearly half of positive cases.

“While we understand no test is perfect, test outcomes depend on a number of factors including patient selection, specimen type, collection, handling, storage, transport and conformity to the way the test was designed to be run,” Abbott said in a statement on Thursday. “ID NOW is intended to be used near the patient with a direct swab test method.”

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

Premier League fixtures: Your club-by-club guide to the 2022-23 seasonon June 16, 2022 at 7:58 am

Find out your club's full fixture list for the 2022-23 Premier League season.Find out your club's full fixture list for the 2022-23 Premier League...

How to Wear Business Casual Outfits to Avoid Distractions

Business casual attire has undergone a sea change since its inception in the year 1940. Unlike its other versions that were originally meant for...

Covid-19: No data to suggest 21 June easing delay, says Kwasi Kwartengon May 28, 2021 at 7:14 am

The government will not rush to conclusions about lifting lockdown in England, Kwasi Kwarteng says.image copyrightReutersThere is currently no evidence that might mean a...

Paul Pogba: Burglars stole World Cup winner’s medal, Man Utd & France midfielder sayson March 22, 2022 at 11:45 pm

Manchester United midfielder Paul Pogba says burglars stole his World Cup winner's medal when they broke into his home.The France international, 29, spoke of...

Sabina Nessa: Man admits murdering south-east London teacheron February 25, 2022 at 2:39 pm

The primary school teacher was found dead in a south-east London park in September last year.Image source, Met PoliceA man has pleaded guilty to...
Home of Science
Follow me